Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide

Annals of Allergy, Asthma and Immunology

Volumn 101, Issue 2, 2008, Pages 124-129

  Khalili, Barzin ^a   Boggs, Peter B ^a   Shi, Runhua ^a   Bahna, Sami L ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; ASTHMA CONTROL TEST; CALCULATION; CHILD; CLINICAL EVALUATION; CORRELATION ANALYSIS; FEMALE; GLOBAL INITIATIVE FOR ASTHMA; HUMAN; INSTRUMENTATION; JOINT TASK FORCE PRACTICE PARAMETER; MAJOR CLINICAL STUDY; MALE; NATIONAL ASTHMA EDUCATION AND PREVENTION PROGRAM; PHYSICIAN; PRIORITY JOURNAL; SPIROMETRY;

EID: 49449101148     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60199-8     Document Type: Article

References (42)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000;161:1720-1745.
2. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: update 2002. J Allergy Clin Immunol. 2002;110(pt 2):S141-S219.
3. Juniper EF, O'Byrne PM, Guyat GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902-907.
4. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59-65.
5. Li JT, Oppenheimer J, Bernstein IL, Nicklas RA. Attaining optimal asthma control: a practice parameter. J Allergy Clin Immunol. 2005;116:S3-11.
6. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Washington, DC: US Department of Health and Human Services; 1995, revised 2006. NIH publication 02-3659. http://www.ginasthma.com/ Guidelineitem.asp?l1=2&l2=1&intId=60. Accessed September 14, 2007.
7. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033-1039.
8. Currie GP, Jackson CM, Lipworth BJ. Does bronchial hyperresponsiveness in asthma matter? J Asthma. 2004;41:247-258.
9. Payne DNR, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med. 2001;164:1376-1381.
10. Warke TJ, Fitch PS, Brown V, et al. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma. Thorax. 2002;57:383-387.
11. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 1998;53:91-95.
12. Strunk RC, Szefler SJ, Phillips BR, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol. 2003;112:883-892.
13. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids: Asthma and Allergy Group. Thorax. 1998;53:1030-1034.
14. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164:738-743.
15. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax. 2002;57:889-896.
16. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 1996;9:196-201.
17. Khalili B, Boggs PB, Bahna SL. Reliability of a new hand-held device for the measurement of exhaled nitric oxide. Allergy. 2007;62:1171-1174.
18. Murphy AW, Platts-Mills TA, Lobo M, Hayden F. Respiratory nitric oxide levels in experimental human influenza. Chest. 1998;114:452-456.
19. Balboa De Paz F, Rueda Esteban S, Aleo Cugan E, Rodriguez Tauriz G. Exhaled nitric oxide in healthy and asthmatic children [in Spanish]. An Esp Pediatr. 2002;57:12-17.
20. Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med. 1995;152:609-612.
21. Olin AC, Aldenbratt A, Ekman A, et al. Increased nitric oxide in exhaled air after intake of a nitrate-rich meal. Respir Med. 2001;95:153-158.
22. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912-930.
23. Standardization of spirometry, 1994 update: American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136.
24. Liu AH, Zeiger R, Sorkness C, et al. Development and cross-sectional validation of the Childhood Asthma Control Test. J Allergy Clin Immunol. 2007;119:817-825.
25. Aerocrine. Exhaled Nitric Oxide: A Noninvasive Marker for Inflammation: Scientific Backgrounder, Updated 2005. Solna, Sweden: Aerocrine Ab; 2005.
26. in't Veen JCCM, Smits HH, Ravensberg AJJ, Hiemstra PS, Sterk PJ, Bel EH. Impaired perception of dyspnea in patients with severe asthma: relation to sputum eosinophils. Am J Respir Crit Care Med. 1998;158:1134-1141.
27. Fuhlbrigge AL, Adams RJ, Guilbert TW, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166:1044-1049.
28. Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? the Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med. 2004;170:836-844.
29. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet. 2002;360:1715-1721.
30. Sont JK, Willems LNA, Bel EH, et al; The AMPUL study group. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med. 1999;159:1043-1051.
31. Pijnenburg MW, Hofhuis W, Hop WC, De Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax. 2005;60:215-218.
32. Harkins MS, Fiato K, Iwamoto GK. Exhaled nitric oxide predicts asthma exacerbation. J Asthma. 2004;41:471-476.
33. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163-2173.
34. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005;172:831-836.
35. Sippel JM, Holden WE, Tilles SA, et al. Exhaled nitric oxide levels correlate with measures of disease control in asthma. J Allergy Clin Immunol. 2000;106:645-650.
36. van den Toorn LM, Prins J-B, Overbeek SE, Hoogsteden HC, de Jongste JC. Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;162:953-957.
37. Baraldi E, Carrà S, Dario C, et al. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am J Respir Crit Care Med. 1999;159:262-266.
38. Limb SL, Brown KC, Wood RA, et al. Irreversible lung function deficits in young adults with a history of childhood asthma. J Allergy Clin Immunol. 2005;116:1213-1219.
39. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax. 2002;57:309-316.
40. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying "well-controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616-621.
41. Vahlkvist S, Sinding M, Skamstrup K, Bisgaard H. Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure. J Allergy Clin Immunol. 2006;117:1272-1276.
42. Nishio K, Odijima H, Motomura C, Nakao F, Nishima S. Effect if inhaled corticosteroid therapy on exhaled nitric oxide and bronchial responsiveness in children with asthma. J Asthma. 2006;43:739-743.